Non-hereditary diseases or associated conditions that cause the  platelets   (the blood cells essential for coagulation) to not function properly.        
                    
                 
                  
                 
                
                
               
               
                
                    
                        Alternative Names
                    
                                   Acquired qualitative platelet disorders; Acquired disorders of platelet function        
                    
                 
                
                    
                        Causes, incidence, and risk factors
                    
                         Platelets   are blood cells that are essential for blood clotting. Platelet disorders can include inappropriate number of platelets (too many or too few), or normal number but inappropriate functioning of the platelets. Any platelet disorder affects blood clotting.  
Disorders of platelet function can be caused by congenital diseases or acquired conditions. Acquired platelet function disorders are disorders of inappropriate platelet function, and that develop as a result of another disease or condition (acquired). In many cases, the  platelet count   may be normal or even elevated, but evidence of a bleeding disorder will be present.  Myeloproliferative disorders   such as primary  thrombocytopenia  ,  polycythemia vera  ,  chronic myelogenous leukemia  , and  myelofibrosis   can produce abnormalities in platelet function. Other causes include  renal failure  ,  multiple myeloma  , and medications such as aspirin, anti-inflammatory medications, penicillins, phenothiazines, prednisone (prolonged use), and others.  
                    
                 
                
                    
                        Treatment
                    
                                   Treatment is directed at the cause of the abnormality.  Dialysis   reduces the  bleeding   tendency if the cause is  renal failure  . Platelet transfusions or plateletpheresis (removal of  platelets   from the blood and replacement with donated platelets) may be indicated in  myeloproliferative disorders  . Medication-induced platelet abnormalities require discontinuation of the medication.        
                    
                 
                
                
                    
                        Expectations (prognosis)
                    
                                   Treatment of the cause of the abnormality usually corrects the defect.        
                    
                 
                
                    
                        Calling your health care provider
                    
                          
 If   bleeding   of unknown cause is present.   
 If symptoms worsen or do not improve after treatment of an acquired platelet function defect. 
                    
                 
                
                    
                        Prevention
                    
                                   Care in the use of medications can reduce the risk of drug-related acquired platelet function defects. Treatment of other disorders may also reduce risk. Some cases are not preventable.